CHOKSI LABORATORIES LTD.
NSE : NABSE : 526546ISIN
CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse
: Private
BSE61.500 (0 % )
PREV CLOSE (Rs.) 61.50
OPEN PRICE (Rs.) 63.65
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 647
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Company News
| Date | Heading | Details |
|---|---|---|
| 18-Apr-2024 | Choksi Laboratories informs about compliance certificate | <div style="text-align: justify;">As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Choksi Laboratories has enclosed Compliance Certificate duly singed by Company Secretary and Compliance Officer of the company and Authorized Representative of the RTA i.e. Link Intime India, in terms of above-mentioned regulation for the Financial Year ended March 31st, 2024. </div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 22-Mar-2024 | Appointment of Director | Inter alia, to consider and approve:- 1. To Consider and approve the appointment of Mrs. Abha Shastri (DIN: 00065772) as Additional Independent Director of the company w.e.f. 01st April, 2024 2. To take on record the cessation of directorship of Mr. Sudarshan Shastri (DIN: 00155105) as Independent Director of the company w.e.f. 01st April, 2024 due to completion of his term; 3. To consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which. 4. Any other item may be taken up for consideration with the permission of the Chairman and presence of at least one independent Director. If any |
| 22-Mar-2024 | Notice of Postal Ballot | Inter alia, to consider and approve:- 1. To Consider and approve the appointment of Mrs. Abha Shastri (DIN: 00065772) as Additional Independent Director of the company w.e.f. 01st April, 2024 2. To take on record the cessation of directorship of Mr. Sudarshan Shastri (DIN: 00155105) as Independent Director of the company w.e.f. 01st April, 2024 due to completion of his term; 3. To consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which. 4. Any other item may be taken up for consideration with the permission of the Chairman and presence of at least one independent Director. If any |
| 22-Mar-2024 | Resignation of Director | Inter alia, to consider and approve:- 1. To Consider and approve the appointment of Mrs. Abha Shastri (DIN: 00065772) as Additional Independent Director of the company w.e.f. 01st April, 2024 2. To take on record the cessation of directorship of Mr. Sudarshan Shastri (DIN: 00155105) as Independent Director of the company w.e.f. 01st April, 2024 due to completion of his term; 3. To consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which. 4. Any other item may be taken up for consideration with the permission of the Chairman and presence of at least one independent Director. If any |
| 03-Feb-2024 | Choksi Laboratories informs about outcome of board meeting | <div style="text-align: justify;">Choksi Laboratories has informed that Board of Directors of the Company at their meeting held on Saturday, 03rd February, 2024 at the registered office of the Company situated at Survey No 9/1, Near Balaji Tulsiyana Industrial Park, Gram Kumerdi, Indore (M.P.) -452010 has transact the following businesses: Considered and approved Un-audited Standalone Financial Results along with Limited Review Reports for the Quarter and Nine month ended on 31st December, 2023; Appointment of Prachi Mantri (DIN: 10491114) as an Additional Director of the Company in the category of the Independent Director of the Company with effective from 03rd of February, 2024 subject to the Conformation of the Members; Prachi Mantri was not related with any of the Present Director of the Company. Taken on record the sad demine of Late Nanoo Krishna Mani, Independent Director of the company; Approve the re-appointment of Surabhi Agrawal, Practicing Company Secretary as Secretarial Auditor of the Company for the Financial Year 2023-24. The meeting of Board of Directors commenced at 12:30 PM and concluded at 01:45 PM.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 10-Nov-2023 | Choksi Laboratories submits unaudited financial results | <p style="text-align: justify;">Pursuant to Regulation 30 & 33 of the SEBT (Listing Obligations and Disclosure Requirements) Regula lions, 2015, Choksi Laboratories has informed that it enclosed the following: Un-audited Standalone Financial Results along with Limited Review Reports for the Quarter and Half Year ended on 30th September, 2023. The aforesaid results are duly approved by the Audit Committee and Board of Directors in their respective meetings held on Friday, 10th November 2023.</p><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 05-Jul-2023 | Choksi Laboratories informs about outcome of board meeting | <div style="text-align: justify;">Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure, Requirements) Regulation 2015, Choksi Laboratories has informed that at the meeting of the Board of Directors Company held on Wednesday the 05th July 2023 at the registered office of the Company situated at Survey No. 9/1, Near Balaji Tulsiyana Industrial Estate, Kumdedi, Indore-452010, MP, have approved the appointment of Prakhar Dubey Company Secretary and Compliance officer of the Company; Approved the resignation of Yash Gupta from the post of Company Secretary and Compliance officer of the Company; Appointment of Meenaxi Patidar (DIN: 10206356) as an Additional Director of the Company in the category of the Independent Director of the Company subject to the Conformation of the Members.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
